Myocardial Stiffness Evaluation Using Noninvasive Shear Wave Imaging in Healthy and Hypertrophic Cardiomyopathic Adults.


Journal

JACC. Cardiovascular imaging
ISSN: 1876-7591
Titre abrégé: JACC Cardiovasc Imaging
Pays: United States
ID NLM: 101467978

Informations de publication

Date de publication:
07 2019
Historique:
received: 26 11 2017
revised: 31 01 2018
accepted: 01 02 2018
pubmed: 20 3 2018
medline: 18 3 2020
entrez: 19 3 2018
Statut: ppublish

Résumé

The goal of our study was to investigate the potential of myocardial shear wave imaging (SWI) to quantify the diastolic myocardial stiffness (MS) (kPa) noninvasively in adult healthy volunteers (HVs) and its physiological variation with age, and in hypertrophic cardiomyopathy (HCM) populations with heart failure and preserved ejection function (HFpEF). MS is an important prognostic and diagnostic parameter of the diastolic function. MS is affected by physiological changes but also by pathological alterations of extracellular and cellular tissues. However, the clinical assessment of MS and the diastolic function remains challenging. SWI is a novel ultrasound-based technique that has the potential to provide intrinsic MS noninvasively. We prospectively included 80 adults: 60 HV (divided into 3 groups: 20- to 39-year old patients [n = 20]; 40- to 59-year-old patients [n = 20]; and 60- to 79-year-old patients [n = 20]) and 20 HCM-HFpEF patients. Echocardiography, cardiac magnetic resonance imaging and biological explorations were achieved. MS evaluation was performed using an ultrafast ultrasound scanner with cardiac phased array. The fractional anisotropy of MS was also estimated. MS increased significantly with age in the HV group (the mean MS was 2.59 ± 0.58 kPa, 4.70 ± 0.88 kPa, and 6.08 ± 1.06 kPa for the 20- to 40-year-old, 40- to 60-year-old, and 60- to 80-year-old patient groups, respectively; p < 0.01 between each group). MS was significantly higher in HCM-HFpEF patients than in HV patients (mean MS = 12.68 ± 2.91 kPa vs. 4.47 ± 1.68 kPa, respectively; p < 0.01), with a cut-off at 8 kPa (area under the curve = 0.993; sensitivity = 95%, specificity = 100%). The fractional anisotropy was lower in HCM-HFpEF (mean = 0.133 ± 0.073) than in HV (0.238 ± 0.068) (p < 0.01). Positive correlations were found between MS and diastolic parameters in echocardiography (early diastolic peak/early diastolic mitral annular velocity, r = 0.783; early diastolic peak/transmitral flow propagation velocity, r = 0.616; left atrial volume index, r = 0.623) and with fibrosis markers in cardiac magnetic resonance (late gadolinium enhancement, r = 0.804; myocardial T1 pre-contrast, r = 0.711). MS was found to increase with age in healthy adults and was significantly higher in HCM-HFpEF patients. Myocardial SWI has the potential to become a clinical tool for the diagnostic of diastolic dysfunction. (Non-invasive Evaluation of Myocardial Stiffness by Elastography [Elasto-Cardio]; NCT02537041).

Sections du résumé

OBJECTIVES
The goal of our study was to investigate the potential of myocardial shear wave imaging (SWI) to quantify the diastolic myocardial stiffness (MS) (kPa) noninvasively in adult healthy volunteers (HVs) and its physiological variation with age, and in hypertrophic cardiomyopathy (HCM) populations with heart failure and preserved ejection function (HFpEF).
BACKGROUND
MS is an important prognostic and diagnostic parameter of the diastolic function. MS is affected by physiological changes but also by pathological alterations of extracellular and cellular tissues. However, the clinical assessment of MS and the diastolic function remains challenging. SWI is a novel ultrasound-based technique that has the potential to provide intrinsic MS noninvasively.
METHODS
We prospectively included 80 adults: 60 HV (divided into 3 groups: 20- to 39-year old patients [n = 20]; 40- to 59-year-old patients [n = 20]; and 60- to 79-year-old patients [n = 20]) and 20 HCM-HFpEF patients. Echocardiography, cardiac magnetic resonance imaging and biological explorations were achieved. MS evaluation was performed using an ultrafast ultrasound scanner with cardiac phased array. The fractional anisotropy of MS was also estimated.
RESULTS
MS increased significantly with age in the HV group (the mean MS was 2.59 ± 0.58 kPa, 4.70 ± 0.88 kPa, and 6.08 ± 1.06 kPa for the 20- to 40-year-old, 40- to 60-year-old, and 60- to 80-year-old patient groups, respectively; p < 0.01 between each group). MS was significantly higher in HCM-HFpEF patients than in HV patients (mean MS = 12.68 ± 2.91 kPa vs. 4.47 ± 1.68 kPa, respectively; p < 0.01), with a cut-off at 8 kPa (area under the curve = 0.993; sensitivity = 95%, specificity = 100%). The fractional anisotropy was lower in HCM-HFpEF (mean = 0.133 ± 0.073) than in HV (0.238 ± 0.068) (p < 0.01). Positive correlations were found between MS and diastolic parameters in echocardiography (early diastolic peak/early diastolic mitral annular velocity, r = 0.783; early diastolic peak/transmitral flow propagation velocity, r = 0.616; left atrial volume index, r = 0.623) and with fibrosis markers in cardiac magnetic resonance (late gadolinium enhancement, r = 0.804; myocardial T1 pre-contrast, r = 0.711).
CONCLUSIONS
MS was found to increase with age in healthy adults and was significantly higher in HCM-HFpEF patients. Myocardial SWI has the potential to become a clinical tool for the diagnostic of diastolic dysfunction. (Non-invasive Evaluation of Myocardial Stiffness by Elastography [Elasto-Cardio]; NCT02537041).

Identifiants

pubmed: 29550319
pii: S1936-878X(18)30140-2
doi: 10.1016/j.jcmg.2018.02.002
pmc: PMC6603249
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02537041']

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

1135-1145

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
JACC Cardiovasc Imaging. 2015 Sep;8(9):1071-1093
pubmed: 26381769
J Am Coll Cardiol. 2016 Apr 19;67(15):1815-1825
pubmed: 27081022
J Cardiovasc Magn Reson. 2013 Oct 08;15:91
pubmed: 24103764
J Am Coll Cardiol. 1991 May;17(6):1343-51
pubmed: 2016452
Radiology. 2012 Jun;263(3):673-7
pubmed: 22523322
Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1321-1360
pubmed: 27422899
Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H403-12
pubmed: 16428349
Circ Res. 1974 Jul;35(1):117-26
pubmed: 4841253
Hepatology. 2010 Feb;51(2):454-62
pubmed: 20101745
Am J Physiol Heart Circ Physiol. 2004 Nov;287(5):H2132-7
pubmed: 15231502
Circulation. 2002 Mar 19;105(11):1387-93
pubmed: 11901053
Eur Heart J Cardiovasc Imaging. 2015 Sep;16(9):1031-41
pubmed: 25896355
Am J Physiol Heart Circ Physiol. 2012 Feb 15;302(4):H885-92
pubmed: 22180656
N Engl J Med. 2004 May 6;350(19):1953-9
pubmed: 15128895
IEEE Trans Ultrason Ferroelectr Freq Control. 2004 Apr;51(4):396-409
pubmed: 15139541
J Am Coll Cardiol. 2008 Nov 4;52(19):1574-80
pubmed: 19007595
J Am Soc Echocardiogr. 2012 Jun;25(6):661-6
pubmed: 22465872
Circulation. 2015 Apr 7;131(14):1247-59
pubmed: 25637629
J Ultrasound Med. 2016 Jul;35(7):1419-27
pubmed: 27208201
Circulation. 2002 Feb 5;105(5):595-601
pubmed: 11827925
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
Echocardiography. 2017 Jan;34(1):6-13
pubmed: 27779335
Circ Res. 2004 Jun 25;94(12):1533-42
pubmed: 15217918
J Physiol. 2012 Apr 15;590(8):1871-80
pubmed: 22331419
Radiology. 2006 Mar;238(3):1004-12
pubmed: 16424239
Phys Med Biol. 2012 Aug 21;57(16):5075-95
pubmed: 22836727
J Am Coll Cardiol. 2004 Jun 16;43(12):2260-4
pubmed: 15193690
J Am Coll Cardiol. 2011 Jun 28;58(1):65-72
pubmed: 21700091
JACC Cardiovasc Imaging. 2018 May;11(5):779-781
pubmed: 29153574
Cardiovasc Res. 1993 Mar;27(3):341-8
pubmed: 8490934
Circulation. 2008 Apr 22;117(16):2051-60
pubmed: 18413502
Eur Heart J. 2014 Oct 14;35(39):2733-79
pubmed: 25173338

Auteurs

Olivier Villemain (O)

Institut Langevin, ESPCI, CNRS, Inserm U979, PSL Research University, Paris, France; Hôpital Européen Georges Pompidou, Université Paris Descartes, Cardio-Vascular Departement, UMR 970, Paris, France.

Mafalda Correia (M)

Institut Langevin, ESPCI, CNRS, Inserm U979, PSL Research University, Paris, France.

Elie Mousseaux (E)

Hôpital Européen Georges Pompidou, Université Paris Descartes, Département de Radiologie, INSERM U970, Paris, France.

Jérome Baranger (J)

Institut Langevin, ESPCI, CNRS, Inserm U979, PSL Research University, Paris, France.

Samuel Zarka (S)

Hôpital Européen Georges Pompidou, Université Paris Descartes, Cardio-Vascular Departement, UMR 970, Paris, France.

Ilya Podetti (I)

Institut Langevin, ESPCI, CNRS, Inserm U979, PSL Research University, Paris, France.

Gilles Soulat (G)

Hôpital Européen Georges Pompidou, Université Paris Descartes, Département de Radiologie, INSERM U970, Paris, France.

Thibaud Damy (T)

Department of Cardiology, AP-HP, Henri Mondor Teaching Hospital, Créteil, France.

Albert Hagège (A)

Hôpital Européen Georges Pompidou, Université Paris Descartes, Cardio-Vascular Departement, UMR 970, Paris, France.

Mickael Tanter (M)

Institut Langevin, ESPCI, CNRS, Inserm U979, PSL Research University, Paris, France.

Mathieu Pernot (M)

Institut Langevin, ESPCI, CNRS, Inserm U979, PSL Research University, Paris, France. Electronic address: mathieu.pernot@espci.fr.

Emmanuel Messas (E)

Hôpital Européen Georges Pompidou, Université Paris Descartes, Cardio-Vascular Departement, UMR 970, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH